Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder CancerIan M. McElree, Vignesh T. Packiam, Ryan L. Steinberg et al.|The Journal of Urology|2022Cited by 71
Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non–Muscle-Invasive Bladder CancerIan M. McElree, Michael A. O’Donnell, Vignesh T. Packiam et al.|The Journal of Urology|2022Cited by 21
Multi-institutional feasibility and safety outcomes of retroperitoneal robot-assisted partial nephrectomy in morbidly obese patientsThomas E. Stout, Paul T. Gellhaus, Ian M. McElree et al.|Translational Andrology and Urology|2023Cited by 2
Reply by AuthorsIan M. McElree, Vignesh T. Packiam, Jordan Richards et al.|The Journal of Urology|2022Cited by 1
PD26-03 SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR BCG-NAïVE HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCERIan M. McElree, Vignesh T. Packiam, Ryan L. Steinberg et al.|The Journal of Urology|2022Cited by 0